Pixium Vision
A bioelectronics company that developed bionic vision systems for retinal diseases.
ALPIX | PA
Overview
Corporate Details
- ISIN(s):
- FR0011950641 (+1 more)
- LEI:
- 96950046OPLRLKKEOO08
- Country:
- France
- Address:
- 74 RUE DU FBG ST ANTOINE, 75012 PARIS 12
- Website:
- https://www.pixium-vision.com/
- Sector:
- Manufacturing
Description
Pixium Vision was a bioelectronics company that developed bionic vision systems to restore partial sight for patients with retinal diseases. Its core technology, the PRIMA System, is a photovoltaic subretinal implant designed to treat vision loss from advanced atrophic dry age-related macular degeneration (dry AMD). The system uses specialized glasses to project near-infrared light onto the implant, which converts the light into electrical signals to stimulate retinal cells and create a form of prosthetic vision. The company's assets, including the PRIMA technology and its ongoing European pivotal trial (PRIMAvera), were acquired by Science Corporation in late 2023. The trials and device manufacturing are now sponsored by La Science SAS.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-10-06 12:07 |
Franchissement de seuils
|
French | 206.7 KB | ||
| 2020-09-28 07:00 |
Pixium Vision notifié d'un franchissement de seuil suite à une dilution passive
|
French | 182.4 KB | ||
| 2020-09-08 09:52 |
Franchissement de seuils
|
French | 200.3 KB | ||
| 2020-07-27 17:00 |
2020 Half-Year Financial Report
|
English | 678.8 KB | ||
| 2020-07-24 19:00 |
RAPPORT FINANCIER SEMESTRIEL 2020
|
French | 698.9 KB | ||
| 2020-07-23 18:00 |
Pixium Vision annonce ses résultats financiers au 30 juin 2020 et fait le point…
|
French | 291.8 KB | ||
| 2020-07-23 18:00 |
Pixium Vision announces its financial results as of June 30 2020 and provides b…
|
English | 290.3 KB | ||
| 2020-07-20 09:44 |
Franchissement de seuils
|
French | 118.6 KB | ||
| 2020-07-16 10:42 |
Franchissement de seuils
|
French | 208.3 KB | ||
| 2020-07-15 07:00 |
À la suite du succès de l'augmentation de capital de plus de 7,3 millions d’eur…
|
French | 255.5 KB | ||
| 2020-07-06 07:00 |
Succès de l’augmentation de capital avec maintien du droit préférentiel de sou…
|
French | 269.7 KB | ||
| 2020-07-06 07:00 |
Success of the capital increase with pre-emptive subscription rights: €7.3 mil…
|
English | 249.7 KB | ||
| 2020-07-01 18:00 |
Bilan du premier semestre 2020 du contrat de liquidité contracté avec la sociét…
|
French | 172.5 KB | ||
| 2020-07-01 18:00 |
Information relative au nombre total de droits de vote et d’actions composant l…
|
French | 142.2 KB | ||
| 2020-06-19 13:28 |
Pixium Vision selected to participate in the Next French Healthcare program org…
|
English | 145.3 KB |
Automate Your Workflow. Get a real-time feed of all Pixium Vision filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pixium Vision
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pixium Vision via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-10 | N/A | Other | Sell | 42,681 | 16,517.55 EUR |
| 2024-01-09 | N/A | Other | Sell | 80,325 | 45,608.54 EUR |
| 2024-01-08 | N/A | Other | Sell | 110,740 | 69,732.98 EUR |
| 2023-12-04 | N/A | Other | Sell | 665 | 60.98 EUR |